tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market
Advertisement

Taiko Pharmaceutical Co., Ltd. (4574) Ratios

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Ratios

JP:4574's free cash flow for Q4 2024 was ¥0.56. For the 2024 fiscal year, JP:4574's free cash flow was decreased by ¥ and operating cash flow was ¥-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
3.07 2.71 3.19 2.65 3.46
Quick Ratio
2.48 2.01 2.45 1.79 3.04
Cash Ratio
1.59 1.11 1.34 0.66 2.07
Solvency Ratio
0.26 -0.79 -1.05 0.46 0.48
Operating Cash Flow Ratio
0.00 -0.71 -0.37 -0.20 0.73
Short-Term Operating Cash Flow Coverage
0.00 -1.87 -1.66 -48.81 135.64
Net Current Asset Value
¥ 3.81B¥ 553.00M¥ 4.05B¥ 10.85B¥ 10.48B
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.25 0.21 <0.01 <0.01
Debt-to-Equity Ratio
0.25 0.47 0.37 <0.01 <0.01
Debt-to-Capital Ratio
0.20 0.32 0.27 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.09 0.25 0.23 <0.01 <0.01
Financial Leverage Ratio
1.62 1.87 1.76 1.39 1.31
Debt Service Coverage Ratio
1.30 -3.50 -6.50 140.33 115.31
Interest Coverage Ratio
78.63 -307.90 -824.67 20.04K 9.71K
Debt to Market Cap
0.13 0.22 0.13 <0.01 <0.01
Interest Debt Per Share
40.54 87.59 109.84 2.20 1.84
Net Debt to EBITDA
-2.02 -0.19 0.18 -0.82 -2.42
Profitability Margins
Gross Profit Margin
58.25%21.41%25.62%70.24%70.82%
EBIT Margin
9.17%0.00%0.00%0.00%0.00%
EBITDA Margin
19.72%-74.40%-51.94%33.50%27.22%
Operating Profit Margin
10.00%-61.09%-46.16%31.96%25.61%
Pretax Profit Margin
8.98%-96.61%-82.90%30.39%23.46%
Net Profit Margin
14.27%-97.10%-89.49%21.78%16.43%
Continuous Operations Profit Margin
14.27%0.00%0.00%0.00%0.00%
Net Income Per EBT
158.94%100.51%107.94%71.67%70.01%
EBT Per EBIT
89.83%158.14%179.61%95.10%91.63%
Return on Assets (ROA)
6.95%-32.53%-42.57%12.13%9.63%
Return on Equity (ROE)
11.39%-60.85%-74.92%16.91%12.66%
Return on Capital Employed (ROCE)
6.25%-25.13%-27.16%23.28%18.49%
Return on Invested Capital (ROIC)
8.85%-23.24%-27.86%16.67%12.93%
Return on Tangible Assets
6.97%-33.01%-43.14%12.25%9.72%
Earnings Yield
5.63%-28.49%-26.76%5.53%3.70%
Efficiency Ratios
Receivables Turnover
2.59 2.80 2.64 2.23 3.38
Payables Turnover
7.77 14.46 25.80 1.80 4.33
Inventory Turnover
1.57 2.03 2.49 0.82 2.15
Fixed Asset Turnover
1.92 0.79 1.51 1.87 2.10
Asset Turnover
0.49 0.33 0.48 0.56 0.59
Working Capital Turnover Ratio
1.04 0.71 0.98 1.47 1.39
Cash Conversion Cycle
326.68 284.84 270.68 404.79 193.37
Days of Sales Outstanding
140.85 130.21 138.10 163.45 108.00
Days of Inventory Outstanding
232.82 179.87 146.72 444.43 169.62
Days of Payables Outstanding
46.98 25.25 14.15 203.09 84.25
Operating Cycle
373.66 310.09 284.82 607.88 277.61
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -45.73 -36.66 -35.12 81.97
Free Cash Flow Per Share
0.00 -47.66 -73.43 -86.65 76.80
CapEx Per Share
0.00 1.93 36.77 51.53 5.17
Free Cash Flow to Operating Cash Flow
0.00 1.04 2.00 2.47 0.94
Dividend Paid and CapEx Coverage Ratio
0.00 -23.74 -0.67 -0.49 4.86
Capital Expenditure Coverage Ratio
0.00 -23.74 -1.00 -0.68 15.86
Operating Cash Flow Coverage Ratio
0.00 -0.52 -0.33 -15.99 44.79
Operating Cash Flow to Sales Ratio
0.00 -0.40 -0.15 -0.09 0.23
Free Cash Flow Yield
0.00%-12.10%-8.91%-5.38%4.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.55 -3.51 -3.74 18.08 27.03
Price-to-Sales (P/S) Ratio
2.50 3.41 3.34 3.94 4.44
Price-to-Book (P/B) Ratio
1.98 2.14 2.80 3.06 3.42
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -8.27 -11.22 -18.60 20.26
Price-to-Operating Cash Flow Ratio
0.00 -8.62 -22.48 -45.90 18.98
Price-to-Earnings Growth (PEG) Ratio
0.13 0.07 0.01 0.33 0.36
Price-to-Fair Value
1.98 2.14 2.80 3.06 3.42
Enterprise Value Multiple
10.68 -4.77 -6.26 10.93 13.89
Enterprise Value
13.46B 17.88B 34.83B 64.77B 56.49B
EV to EBITDA
10.84 -4.77 -6.26 10.93 13.89
EV to Sales
2.14 3.55 3.25 3.66 3.78
EV to Free Cash Flow
0.00 -8.61 -10.90 -17.31 17.26
EV to Operating Cash Flow
0.00 -8.97 -21.84 -42.70 16.17
Tangible Book Value Per Share
158.09 184.46 294.31 527.48 454.58
Shareholders’ Equity Per Share
158.62 184.46 294.31 527.48 454.58
Tax and Other Ratios
Effective Tax Rate
-0.59 >-0.01 -0.08 0.28 0.30
Revenue Per Share
125.35 115.59 246.39 409.46 350.46
Net Income Per Share
17.89 -112.24 -220.48 89.18 57.57
Tax Burden
1.59 1.01 1.08 0.72 0.70
Interest Burden
0.98----
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.41 0.18 -0.28 1.00
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis